Charlson comorbidity index in ischemic stroke and intracerebral hemorrhage as predictor of mortality and functional outcome after 6 months

J Stroke Cerebrovasc Dis. 2013 Oct;22(7):e214-8. doi: 10.1016/j.jstrokecerebrovasdis.2012.11.014. Epub 2013 Jan 22.

Abstract

Background: The Charlson Comorbidity Index (CCI) is commonly used in outcome and mortality studies. Our aim was to investigate the association between CCI score and the functional outcome and mortality 6 months after ischemic stroke (IS) or intracerebral hemorrhage.

Methods: This was a prospective observational cohort of patients with spontaneous intracerebral hemorrhage and IS admitted to the stroke unit during 18 months. The modified Rankin scale (mRS) score was obtained for subjects 6 months after event. The CCI score was dichotomized (low comorbidity 0 or 1 versus high ≥ 2) for analysis. The mRS score was also dichotomized (good outcome, mRS score 0 or 1 versus poor outcome, mRS score ≥ 2).

Results: In all, 175 patients were enrolled in the study. Logistic regression showed that those with a high CCI score (≥ 2) had 37.3% increased odds of having a poor outcome (≥ 2) at 6 months and 68.4% greater odds of death at 6 months.

Conclusions: Comorbid medical conditions independently influence outcome after IS or intracerebral hemorrhage.

Keywords: Charlson index; Ischemic stroke; comorbidity; intracerebral hemorrhage; mortality; outcome assessment.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Brain Ischemia / epidemiology*
  • Brain Ischemia / mortality
  • Cerebral Hemorrhage / epidemiology*
  • Cerebral Hemorrhage / mortality
  • Comorbidity
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prognosis
  • Prospective Studies
  • Stroke / epidemiology*
  • Stroke / mortality